Michael B. Lensing

  • PhD
  • +47 23 01 60 67

Publications 2019

Flores-García L, Lensing MB, Ytterstad E, Eisemann M (2019)
Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study
Atten Defic Hyperact Disord (in press)
DOI 10.1007/s12402-019-00297-5, PubMed 30903585

Publications 2018

Kooij JJS, Bijlenga D, Salerno L, Jaeschke R, Bitter I, Balázs J, Thome J, Dom G, Kasper S, Nunes Filipe C, Stes S, Mohr P, Leppämäki S, Casas M, Bobes J, Mccarthy JM, Richarte V, Kjems Philipsen A, Pehlivanidis A, Niemela A, Styr B, Semerci B, Bolea-Alamanac B, Edvinsson D, Baeyens D et al. (2018)
Updated European Consensus Statement on diagnosis and treatment of adult ADHD
Eur Psychiatry, 56, 14-34
DOI 10.1016/j.eurpsy.2018.11.001, PubMed 30453134

Ogrim G, Lensing MB, Fredriksen M (2018)
Weak scientific basis for criticism of AD/HD medication
Tidsskr. Nor. Laegeforen., 138 (6), 516-517

Øgrim G, Lensing MB, Fredriksen M (2018)
Svakt vitenskapelig grunnlag for kritikk av AD/HD-medisinering
Tidsskr Nor Laegeforen, 138 (6)
DOI 10.4045/tidsskr.18.0187, PubMed 29557125

Publications 2016

Flores-García L, Ytterstad E, Lensing MB, Eisemann M (2016)
Exploring Personality and Readiness to Change in Patients With Substance Use Disorders With and Without ADHD
J Atten Disord, 1087054716677819 (in press)
DOI 10.1177/1087054716677819, PubMed 27866153

Torgersen T, Gjervan B, Lensing MB, Rasmussen K (2016)
Optimal management of ADHD in older adults
Neuropsychiatr Dis Treat, 12, 79-87
DOI 10.2147/NDT.S59271, PubMed 26811680

Publications 2014

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2014)
Psychopharmacological treatment of ADHD in adults aged 50+: an empirical study
J Atten Disord, 19 (5), 380-9
DOI 10.1177/1087054714527342, PubMed 24681898

Publications 2013

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013)
Four-year outcome in psychopharmacologically treated adults with attention-deficit/hyperactivity disorder: a questionnaire survey
J Clin Psychiatry, 74 (1), e87-93
DOI 10.4088/JCP.12m07714, PubMed 23419235

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013)
Quality of life in adults aged 50+ with ADHD
J Atten Disord, 19 (5), 405-13
DOI 10.1177/1087054713480035, PubMed 23514676

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2013)
Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians
Atten Defic Hyperact Disord, 5 (4), 369-76
DOI 10.1007/s12402-013-0116-8, PubMed 23975605

Publications 2011

Bilenberg N, Gillberg C, Houmann T, Kadesjø B, Lensing MB, Plessen KJ, Strand G, Thomsen PH, Worning A (2011)
Prescription rates of ADHD medication in the Scandinavian countries and their national guidelines
Nord J Psychiatry, 66 (1), 70-1
DOI 10.3109/08039488.2011.593102, PubMed 21958313

Publications 2010

Kooij SJ, Bejerot S, Blackwell A, Caci H, Casas-Brugué M, Carpentier PJ, Edvinsson D, Fayyad J, Foeken K, Fitzgerald M, Gaillac V, Ginsberg Y, Henry C, Krause J, Lensing MB, Manor I, Niederhofer H, Nunes-Filipe C, Ohlmeier MD, Oswald P, Pallanti S, Pehlivanidis A, Ramos-Quiroga JA, Rastam M, Ryffel-Rawak D et al. (2010)
European consensus statement on diagnosis and treatment of adult ADHD: The European Network Adult ADHD
BMC Psychiatry, 10, 67
DOI 10.1186/1471-244X-10-67, PubMed 20815868

Publications 1999

Aanonsen NO, Lensing MB, Mathiesen T (1999)
[Central nervous system stimulants in AD/HD in adults]
Tidsskr Nor Laegeforen, 119 (1), 82-3
PubMed 10025211

Page visits: 186